ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients

Du, Songtao; Zeng, Furong; Sun, Huiyan; Liu, Yanlong; Han, Peng; Zhang, Bomiao; Xue, Weinan; Deng, Guangtong*; Yin, Mingzhu*; Cui, Binbin*哈尔滨医科大学
Bioengineered2022-2-1DOI: 10.1080/21655979.2021.2017627
23被引15阅读
引用收藏
分享

摘要

Increasing studies have highlighted the importance of ferroptosis in colorectal cancer (CRC). However, how to use ferroptosis-related genes (FRGs) to predict the prognosis and guide the treatment of CRC remains unknown. To build a prognostic prediction model using the GEO and TCGA databases and explored a therapeutic strategy for CRC patients based on FRGs. A total of 60 FRGs were identified and three of them including ACACA, GSS, and NFS1 were associated with the prognosis of CRC. Using Lasso regression analysis, an FRGs signature was constructed and validated as an independent prognostic predictor. Then we developed a nomogram based on the FRGs signature and clinical prognostic factors to predict the prognosis of CRC patients, which was better than the traditional TNM staging system. Single-sample gene set enrichment analysis (ssGSEA) was further performed for the functional analysis and suggested that JAK-STAT signaling, Ras signaling pathway, MAPK signaling pathway, and PI3K-Akt signaling pathway were significantly enriched in CRC patients with higher FRGs risk score. Interestingly, CRC cells with higher FRGs risk score were more sensitive to RSL3. Knocking down GSS and NFS1 increased the FRGs risk score and the sensitivity of CRC cells to RSL3. For the clinic use, we screened 75 FDA-approved cancer drugs and found that Fludarabine phosphate could decrease the expression of GSS and NFS1 most. Fludarabine phosphate, in combination with RSL3, showed a strong synergistic effect on CRC cells. Together, this study identified a potent prognostic model and provided an alternative individualized treatment for CRC patients.

学科与关键词

关键词
Ferroptosis-related genescolorectal cancersignaturersl3fludarabine phosphate
相关
加载中…
  • Development of a prognostic model based on ferroptosis-related genes for colorectal cancer patients and exploration of the biological functions of NOS2 in vivo and in vitro
    Li, Hongming; Feng, Xiaochuang; Hu, Yong; Wang, Junjiang; Huang, Chengzhi*; Yao, Xueqing*Frontiers in Oncology, 2023, 13: 1133946.被引 1
  • The construction of a novel ferroptosis-related lncRNA model to predict prognosis in colorectal cancer patients
    Chen, Weihong; Deng, Jianzhi; Zhou, Yuehan*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(10).
  • Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer
    Zhang, Heng-Chun; Deng, Shen-Hui; Pi, Ya-Nan; Guo, Jun-Nan; Xi, Hua; Shi, Xin; Yang, Xue-Fei; Zhang, Bo-Miao; Xue, Wei-Nan; Cui, Bin-Bin*; Liu, Yan-Long*Frontiers in Immunology, 2022, 13: 855849.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioengineered
发表日期
2022-02-01
卷期
第 13 卷, 第 2 期
页码
2498-2512
DOI
10.1080/21655979.2021.2017627
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82102803, 82103183]

作者

  • D

    Du, Songtao (第一作者)

    harbin med univ

  • Z

    Zeng, Furong

查看全部 10 位作者收起作者
  • S

    Sun, Huiyan

  • L

    Liu, Yanlong

    harbin med univ

  • H

    Han, Peng

    harbin med univ

  • Z

    Zhang, Bomiao

    harbin med univ

  • X

    Xue, Weinan

    harbin med univ

  • D

    Deng, Guangtong (通讯)

  • Y

    Yin, Mingzhu (通讯)

  • C

    Cui, Binbin (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417